48 Stocks Moving In Wednesday's Mid-Day Session

Gainers

• Co-Diagnostics Inc CODX jumped 209.5 percent to $3.4355 after the company announced the sale of 3 million preferred shares convertible to common stock at $1.20 per share, along with the elimination of $2 million in debt.
• China SXT Pharmaceuticals, Inc. SXTC gained 59.5 percent to $6.70.
• Eyenovia Inc EYEN shares climbed 28.9 percent to $3.3899 after the company's MIST-1 mydriasis study met its primary endpoint.
• Ekso Bionics Holdings Inc EKSO climbed 17.8 percent to $1.92 after the company announced a $100 million exoskeleton joint venture to serve China and other Asian markets.
• Cleveland-Cliffs Inc. CLF gained 16 percent to $10.65 after iron ore futures rose 9 percent due to an expected decrease in production from Brazillian miner Vale.
• Advanced Micro Devices, Inc. AMD shares rose 14.3 percent to $22.00 despite reporting a fourth-quarter sales miss. Fourth-quarter earnings came in at 8 cents per share, falling in-line with analyst estimates. Revenues came in at $1.42 billion, missing estimates by $30 million. The company issued first-quarter sales guidance of $1.2 billion.
• Biohaven Pharmaceutical Holding Company Ltd. BHVN gained 14.3 percent to $39.65 after the company received a 'May Proceed' letter from the FDA for its Phase 3 clinical trial of BHV-3241 for multiple system atrophy.
• Onconova Therapeutics, Inc. ONTX climbed 13.2 percent to $2.32.
• Conn's, Inc. CONN shares gained 12.8 percent to $21.30. Conn's will replace Electro Scientific Industries in the S&P SmallCap 600 on Monday, February 4.
• Companhia Siderúrgica Nacional SID shares climbed 12.1 percent to $2.915.
• Mercury Systems, Inc. MRCY rose 11.6 percent to $56.49 following Q2 earnings.
• LAIX Inc. LAIX climbed 10.2 percent to $10.45.
• Anthem, Inc. ANTM gained 10.2 percent to $300.30 after the company announced strong 2019 guidance and reported better than expected Q4 EPS and revenue results. Anthem raised its Qtr dividend from $0.75 to $0.80 per share.
• Stryker Corporation SYK gained 10 percent to $177.13 after the company reported better than expected Q4 EPS and revenue results. The company also said it expects 2019 EPS of $8.00 to $8.20 versus the $8.01 estimate.
• Titan Medical Inc. TMDI climbed 9.7 percent to $3.4020.
• Vale S.A. VALE shares rose 8.5 percent to $12.45 after gaining 2.50 percent on Tuesday.
• FNCB Bancorp, Inc. FNCB gained 8.4 percent to $10.59.
• ICICI Bank Limited IBN rose 7.7 percent to $10.45 after reporting Q3 earnings.
• Freeport-McMoRan Inc. FCX gained 7 percent to $11.19 after iron ore futures rose 9 percent due to an expected decrease in production from Brazillian miner Vale.
• Royal Caribbean Cruises Ltd. RCL climbed 6.8 percent to $119.71 after the company reported Q4 EPS of $1.53 versus the $1.51 analyst estimate and revenue of $2.33B versus the $2.31B analyst estimate.
• Boeing Co BA rose 6.5 percent to $388.45 after the company posted upbeat Q4 results and issued strong FY19 forecast.
• Grindrod Shipping Holdings Ltd. GRIN rose 6.4 percent to $6.70 after dropping 7.35 percent on Tuesday.
• Mellanox Technologies, Ltd. MLNX gained 6 percent to $86.50 following media reports Intel made a $5.5 billion-$6 billion acquisition offer for the company.
• Apple Inc. AAPL rose 4.9 percent to $162.14 after the company reported stronger-than-expected results for its first quarter. The company issued weak second-quarter sales guidance.

Check out these big penny stock gainers and losers

Losers

• AC Immune SA ACIU shares dipped 64.7 percent to $3.7899 after collaboration partner Roche decided to discontinue phase 3 studies of Crenezumab in Alzheimer's disease.
• Tupperware Brands Corporation TUP declined 27 percent to $27.87 after the company missed Q4 sales estimates and provided soft Q1 and FY19 EPS guidance.
• NF Energy Saving Corporation NFEC dipped 17.8 percent to $7.07.
• 8x8, Inc. EGHT fell 12 percent to $17.00 after reporting a third-quarter sales miss. Earnings came in at $(0.06) per share.
• Coherent, Inc. COHR dropped 11.2 percent to $109.10 following Q1 results.
• Trevena Inc TRVN fell 10.6 percent to $1.1350 after the company announced a $10M registered direct stock offering at $1 per share.
• Silicon Laboratories SLAB dipped 10.4 percent to $80.22 after the company reported worse than expected Q4 EPS and revenue results.
• Scorpio Bulkers Inc. SALT tumbled 9.9 percent to $4.82.
• Avalon GloboCare Corp. AVCO shares dropped 9.7 percent to $5.57.
• Juniper Networks, Inc. JNPR fell 9 percent to $25.46. Juniper reported upbeat earnings for its fourth quarter, while sales missed views. The company also issued weak Q1 guidance.
• OncoCyte Corporation OCX shares dipped 9 percent to $5.38.
• Wabash National Corporation WNC shares fell 8.3 percent to $13.77 following downbeat Q4 earnings.
• Aquestive Therapeutics, Inc. AQST dropped 8.2 percent to $7.05.
• Gentex Corporation GNTX shares fell 7.6 percent to $21.29 after reporting downbeat Q4 earnings.
• Golden Ocean Group Limited GOGL fell 7.4 percent to $5.03.
• Discovery, Inc. DISCA fell 7 percent to $25.49 after competitor AT&T announced worse than expected Q4 results.
• Hawaiian Holdings, Inc. HA dropped 7 percent to $30.70 after the company reported mixed Q4 earnings, missing on EPS but beating on sales.
• National Instruments Corporation NATI fell 7 percent to $41.78 following Q4 results.
• Franklin Resources, Inc. BEN shares slipped 7 percent to $29.02 after the company announced Q1 EPS of $0.54 versus the $0.65 analyst estimate and worse than expected revenue results.
• Banco Santander (Brasil) S.A. BSBR dropped 5.6 percent to $12.46 after the company announced worse than expected Q4 results.
• T. Rowe Price Group, Inc. TROW fell 5.5 percent to $87.69 after the company announced Q4 EPS of $1.54 versus the $1.70 analyst estimate. Revenue was also below the analyst estimate.
• AT&T Inc. T fell 5 percent to $29.16. AT&T reported in-line earnings for its fourth quarter, while sales missed estimates.
• Illumina, Inc. ILMN dropped 5 percent to $271.13 after Leerink Swan lowered its price target for the stock from $380 to $365 per share and pharmaceutical giant Amgen announced disappointing 2019 financial expectations.
• Principal Financial Group, Inc. PFG fell 4.8 percent to $47.27 after the company reported Q4 EPS of $1.11 versus the $1.31 analyst estimate.